Andrew Stewart Plump - 18 Mar 2026 Form 3 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Role: President, R&D, Director
Signature: /s/ Max Heuer, by power of attorney, for Andrew Plump
Issuer symbol: TAK
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 06:08:02 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Plump Andrew Stewart	President, R&D, Director	300 MASSACHUSETTS AVE., CAMBRIDGE	/s/ Max Heuer, by power of attorney, for Andrew Plump	18 Mar 2026	0001977689

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TAK	American Depositary Shares						594,102	18 Mar 2026	Direct	F1
holding	TAK	American Depositary Shares						281,307	18 Mar 2026	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 251,962 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (117,008 shares), July 1, 2027 (91,580 shares) and July 1, 2028 (43,374 shares).

Remarks:

Exhibit 24 Power of Attorney